Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Profit After Tax: 2019-2024

Historic Profit After Tax for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Dec 2024 value amounting to $145.5 million.

  • Harmony Biosciences Holdings' Profit After Tax rose 10.35% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $185.7 million, marking a year-over-year increase of 51.42%. This contributed to the annual value of $145.5 million for FY2024, which is 12.91% up from last year.
  • According to the latest figures from FY2024, Harmony Biosciences Holdings' Profit After Tax is $145.5 million, which was up 12.91% from $128.9 million recorded in FY2023.
  • In the past 5 years, Harmony Biosciences Holdings' Profit After Tax ranged from a high of $181.5 million in FY2022 and a low of -$36.9 million during FY2020.
  • In the last 3 years, Harmony Biosciences Holdings' Profit After Tax had a median value of $145.5 million in 2024 and averaged $151.9 million.
  • Per our database at Business Quant, Harmony Biosciences Holdings' Profit After Tax surged by 424.52% in 2022 and then decreased by 28.99% in 2023.
  • Over the past 5 years, Harmony Biosciences Holdings' Profit After Tax (Yearly) stood at -$36.9 million in 2020, then skyrocketed by 193.65% to $34.6 million in 2021, then surged by 424.52% to $181.5 million in 2022, then decreased by 28.99% to $128.9 million in 2023, then rose by 12.91% to $145.5 million in 2024.